HPV and Cervical Screening National Rollout Across 1200 GP Practices

This programme delivered the national rollout of HPV primary screening across approximately 1,200 GP practices. The rollout encompassed system deployment, laboratory integration, practice-level training, and operational support to ensure a smooth transition from cytology-based screening to the new HPV-first pathway. Here's how this large-scale healthcare programme was structured and delivered.

1. Understanding the Programme Scope

The transition to HPV primary screening represented a fundamental change in how cervical screening samples were processed and reported. Rather than a straightforward technology deployment, this programme required coordination across GP practices, pathology laboratories, screening coordinators, and national programme teams. I led the programme planning, defining the scope, phasing, dependencies, and success criteria needed to manage a rollout of this scale while maintaining continuity of the screening service throughout the transition.

2. System Deployment Across 1,200 Practices

Deploying screening system changes across approximately 1,200 GP practices required a highly structured approach. Each practice operated with its own clinical system configuration, local workflows, and staffing constraints. I designed a deployment methodology that included:

1. Pre-deployment readiness checks: Assessing each practice's system version, connectivity, and configuration before scheduling deployment to minimise failed installations.
2. Automated deployment tooling: Utilising automated deployment scripts where possible to ensure consistency and reduce the need for on-site engineering visits.
3. Regional phasing: Grouping practices by geographic region to enable efficient support coverage and coordinated go-live activities.

3. Laboratory Integration

The new HPV screening pathway required integration between GP practice systems and pathology laboratory information management systems (LIMS). I coordinated the technical integration work, ensuring that sample tracking, result reporting, and failsafe mechanisms operated correctly across the new pathway. This included validating message formats, testing end-to-end data flows, and working with laboratory teams to ensure their systems were configured to handle the new sample types and reporting requirements.

4. Training and Change Management

Clinical and administrative staff across 1,200 practices needed to understand both the clinical rationale for the change and the practical implications for their daily workflows. I established a training programme that combined online learning resources with targeted face-to-face sessions for key staff. Training materials were developed in collaboration with clinical leads to ensure accuracy and relevance, and a network of regional champions was established to provide ongoing peer support after the initial training period.

5. Operational Support During Transition

Maintaining the screening service throughout the transition was a non-negotiable requirement. I established enhanced operational support arrangements for each deployment phase, including dedicated helpdesk resources, rapid issue escalation processes, and on-call technical support during go-live periods. Issues were tracked centrally and categorised by severity, enabling the programme team to identify systemic problems quickly and deploy fixes across the estate rather than resolving issues practice by practice.

6. Quality Assurance and Compliance

Screening programmes operate within a strict quality assurance framework, and any disruption to screening accuracy or timeliness carries significant patient safety implications. I implemented quality assurance checkpoints throughout the rollout, including post-deployment validation of result reporting accuracy, monitoring of screening turnaround times, and regular reporting to the national programme team. Compliance with national screening standards was maintained throughout the transition, with no degradation in screening service quality.

Conclusion

The successful rollout of HPV primary screening across 1,200 GP practices demonstrated the value of structured programme management in delivering large-scale healthcare change. By combining rigorous deployment planning with effective training, operational support, and quality assurance, the programme delivered a seamless transition to the new screening pathway while maintaining service continuity and compliance with national standards throughout.